- Home
- Equipment
- usa maryland
- bone marrow
Refine by
Bone Marrow Equipment Supplied In Usa Maryland
7 equipment items found
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Advancing your research into hematological malignancies, immunology, and other related areas requires access to high quality human bone marrow mononuclear cells. Precision for Medicine has an extensive inventory of normal, healthy donors with longitudinal data and ability to recall for additional biospecimen ...
Manufactured by:RoosterBio, Inc. based inFrederick, MARYLAND (USA)
cGMP xeno-free human bone marrow-derived MSCs to support allogenic therapeutic cell manufacturing. Using a comprehensive and qualified supply chain of our high volume, well-characterized, and standardized WCBs (working cell banks) for large scale cell manufacturing – you’re now able to bypass major steps in cGMP manufacturing. ...
Manufactured by:RoosterBio, Inc. based inFrederick, MARYLAND (USA)
RoosterVial™-hBM are Human Bone-Marrow Derived Mesenchymal Stem/Stromal Cells (hBM-MSCs) isolated from adult human iliac crest from a variety of normal, healthy donors and expanded to a population doubling level (PDL) of 6-10, post-mononuclear cell isolation. Available in both 1M or high-volume 10M cell per vial formats to meet your needs throughout ...
Manufactured by:RoosterBio, Inc. based inFrederick, MARYLAND (USA)
RoosterVial™-hBM-XF are Human Bone-Marrow Derived Mesenchymal Stem/Stromal Cells (hBM-MSCs) isolated from adult human iliac crest from a variety of normal, healthy donors and expanded to a population doubling level (PDL) of 6-10, post-mononuclear cell isolation. Available in both 1M or high-volume 10M cell per vial formats to meet your needs throughout ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic substrate accumulation in organs and tissues of patients ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic substrate accumulation in organs and tissues of patients ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality ...